YU44736B - Process for obtaining tricyclic benzo-condensed compounds - Google Patents

Process for obtaining tricyclic benzo-condensed compounds

Info

Publication number
YU44736B
YU44736B YU606/83A YU60683A YU44736B YU 44736 B YU44736 B YU 44736B YU 606/83 A YU606/83 A YU 606/83A YU 60683 A YU60683 A YU 60683A YU 44736 B YU44736 B YU 44736B
Authority
YU
Yugoslavia
Prior art keywords
condensed compounds
obtaining
benzo
tricyclic benzo
obtaining tricyclic
Prior art date
Application number
YU606/83A
Other languages
English (en)
Other versions
YU60683A (en
Inventor
J F Eggler
M R Johnson
Jr L S Melvin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU60683A publication Critical patent/YU60683A/xx
Publication of YU44736B publication Critical patent/YU44736B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/33—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups or etherified hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C07C33/20—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
YU606/83A 1982-03-16 1983-03-14 Process for obtaining tricyclic benzo-condensed compounds YU44736B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/358,569 US4476131A (en) 1982-03-16 1982-03-16 Substituted hexahydropyrrolo[1,2-a]-quinolines, hexahydro-1H-pyrido[1,2-a]-q

Publications (2)

Publication Number Publication Date
YU60683A YU60683A (en) 1986-04-30
YU44736B true YU44736B (en) 1991-02-28

Family

ID=23410189

Family Applications (2)

Application Number Title Priority Date Filing Date
YU606/83A YU44736B (en) 1982-03-16 1983-03-14 Process for obtaining tricyclic benzo-condensed compounds
YU1757/85A YU44899B (en) 1982-03-16 1985-11-11 Process for making tricyclo-benzo condensed derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU1757/85A YU44899B (en) 1982-03-16 1985-11-11 Process for making tricyclo-benzo condensed derivatives

Country Status (27)

Country Link
US (1) US4476131A (ro)
EP (1) EP0090516B1 (ro)
JP (2) JPS58170724A (ro)
KR (2) KR870001126B1 (ro)
AR (1) AR240936A1 (ro)
AT (1) ATE35544T1 (ro)
AU (1) AU543215B2 (ro)
CA (1) CA1254567A (ro)
CS (1) CS249126B2 (ro)
DD (2) DD219765A5 (ro)
DE (1) DE3377280D1 (ro)
DK (1) DK85183A (ro)
ES (2) ES520630A0 (ro)
FI (1) FI76334C (ro)
GR (1) GR77127B (ro)
HU (1) HU189906B (ro)
IE (1) IE54897B1 (ro)
IL (1) IL68131A (ro)
NO (1) NO162385B (ro)
NZ (1) NZ203577A (ro)
PH (1) PH19998A (ro)
PL (2) PL141501B1 (ro)
PT (1) PT76390B (ro)
RO (2) RO88221B (ro)
SU (1) SU1355130A3 (ro)
YU (2) YU44736B (ro)
ZA (1) ZA831781B (ro)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576964A (en) * 1982-03-16 1986-03-18 Pfizer Inc. Substituted hexahydrobenzo[e]indene and octahydrophenanthrene CNS agents and pharmaceutical compositions thereof
US4670562A (en) * 1985-03-13 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Dihydropyrrolo[1,2-b]isoquinolinedione oximes
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
CA2187257A1 (en) * 1995-10-12 1997-04-13 Enrique Luis Michelotti Aryl-substituted cycloalkanes and cycloalkenes and herbicidal use thereof
CN1075498C (zh) * 1997-05-08 2001-11-28 车庆明 一种查尔酮c甙和它的用途
US6316734B1 (en) 2000-03-07 2001-11-13 3M Innovative Properties Company Flexible circuits with static discharge protection and process for manufacture
ITGE20080051A1 (it) 2008-06-04 2009-12-05 Matteucci Francesco Metodo per la realizzazione di cavi diamantati rinforzati per il taglio di strutture e materiali in acciaio,calcestruzzo,acciaio e calcestruzzo,materiali litoidi o simili e cavo diamantato rinforzato ottenuto mediante tale metodo.
CN112778241A (zh) * 2021-03-09 2021-05-11 中国科学院兰州化学物理研究所 一种四氢呋喃乙酸及其酯类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3045020A (en) * 1962-07-17 x xcooa
FR1490023A (fr) * 1965-08-17 1967-07-28 Sandoz Sa Dérivés de l'isoquinoléine et leur préparation
US4260764A (en) * 1976-12-22 1981-04-07 Pfizer Inc. 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
US4188495A (en) * 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor

Also Published As

Publication number Publication date
NO162385B (no) 1989-09-11
EP0090516A1 (en) 1983-10-05
KR870001126B1 (ko) 1987-06-09
JPH0260653B2 (ro) 1990-12-17
AU1244883A (en) 1983-09-22
AR240936A1 (es) 1991-03-27
CA1254567A (en) 1989-05-23
IL68131A (en) 1986-07-31
IL68131A0 (en) 1983-06-15
ES8503510A1 (es) 1985-03-01
AU543215B2 (en) 1985-04-04
DE3377280D1 (en) 1988-08-11
GR77127B (ro) 1984-09-07
SU1355130A3 (ru) 1987-11-23
DK85183A (da) 1983-09-17
FI830857A0 (fi) 1983-03-15
EP0090516B1 (en) 1988-07-06
NZ203577A (en) 1985-09-13
PL141640B1 (en) 1987-08-31
JPS63183542A (ja) 1988-07-28
US4476131A (en) 1984-10-09
PL141501B1 (en) 1987-07-31
CS249126B2 (en) 1987-03-12
IE830559L (en) 1983-09-16
YU175785A (en) 1986-08-31
RO85382A (ro) 1984-11-25
PT76390A (en) 1983-04-01
AR240936A2 (es) 1991-03-27
RO88221A (ro) 1985-12-30
FI76334B (fi) 1988-06-30
RO85382B (ro) 1984-11-30
ES527075A0 (es) 1985-04-16
ES520630A0 (es) 1985-03-01
PT76390B (en) 1986-02-03
ZA831781B (en) 1983-11-30
ATE35544T1 (de) 1988-07-15
FI76334C (fi) 1988-10-10
ES8504097A1 (es) 1985-04-16
HUT34146A (en) 1985-02-28
FI830857L (fi) 1983-09-17
KR880006969A (ko) 1988-07-25
HU189906B (en) 1986-08-28
KR840004111A (ko) 1984-10-06
PH19998A (en) 1986-08-28
DD219765A5 (de) 1985-03-13
NO830900L (no) 1983-09-19
PL240989A1 (en) 1984-06-18
RO88221B (ro) 1986-01-02
YU44899B (en) 1991-04-30
IE54897B1 (en) 1990-03-14
YU60683A (en) 1986-04-30
DK85183D0 (da) 1983-02-24
KR880002412B1 (ko) 1988-11-08
PL245846A1 (en) 1984-08-27
DD210270A5 (de) 1984-06-06
JPS58170724A (ja) 1983-10-07

Similar Documents

Publication Publication Date Title
RO86234B (ro) Procedeu pentru prepararea unor derivati de aciloxipurine substituite
YU224883A (en) Process for obtaining aluminium n-phosphonomethyglycine
YU43654B (en) Process for obtaining new cephalosporine derivatives
YU237283A (en) Process for obtaiing 7-carboxy-methoxy-phenyl-acetamido-3-cephem derivatives
YU43554B (en) Process for obtaining new platinum-(ii)-diaminic complex
YU43822B (en) Process for obtaining new cephalosporinic derivatives
YU196583A (en) Process for obtaining (1-arylcyclobutyl)-alkylamine compounds
YU60683A (en) Process for obtaining tricyclic benzo-condensed compounds
ZA834366B (en) Tricyclic compounds
YU63183A (en) Process for obtaining bicyclic benzo-condensed compounds
PT77867A (en) Process for preparing aralkyltriazole compounds
PH22140A (en) Tricyclic compounds
YU246583A (en) Process for making 14-acyloxi-2-halo-antracycline derivatives
YU44758B (en) Process for obtaining new phenothiazino derivatives
YU43557B (en) Process for obtaining new spiro-3-hetero azolines
YU42856B (en) Process for obtaining new cycloalcanic derivatives
YU180383A (en) Process for obtaining substituted 1-pyridiloxi-3-indolylalkylamino-2-propanole
IL70220A0 (en) Process for 1-oxa-beta-lactams
YU169783A (en) Process for obtaining new 28-methyl-brassionosteroid derivatives
GB2115809B (en) Process for preparing 4-amino-5-dialkoxy-methylpyrimidine derivatives
PH21657A (en) 7b-amino-2-alkyl-1-oxa-1 dethiacephalosporin compounds and process for preparing said compound
YU52483A (en) Process for obtaining pentacyclic compounds
YU43419B (en) Process for obtaining new izoquinolinic derivatives
YU183883A (en) Process for fat-separation
YU224886A (en) Process for obtaining substituted 1-pyridiloxi-3-indolylalkylamino-2-propanole